UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

Annals of oncology, 2013-01, Vol.24 (1), p.257-263

2013

Volltextzugriff (PDF)

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

Annals of oncology, 2016-10, Vol.27 (10), p.1855-1860

2016

Volltextzugriff (PDF)

Oral complications of targeted cancer therapies: A narrative literature review

Oral oncology, 2011-06, Vol.47 (6), p.441-448

2011

Volltextzugriff (PDF)

KS in the era of HAART: A single institutional retrospective review

Annals of oncology, 2018-10, Vol.29, p.viii590-viii590

2018

Volltextzugriff (PDF)

Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy

JNCI : Journal of the National Cancer Institute, 2010-01, Vol.102 (1), p.47-53

2010

Volltextzugriff (PDF)

Trends in Head and Neck Squamous Cell Carcinoma (HNSCC) Clinical Research as Reported in the American Society of Clinical Oncology (ASCO) Proceedings From 1996 to 2015

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.906-906

2016

Volltextzugriff (PDF)

Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

Annals of oncology, 2018-10, Vol.29, p.viii592-viii592

2018

Volltextzugriff (PDF)

Perceptions of clinical trial enrollment in patients with bone and soft tissue sarcoma

Annals of oncology, 2018-10, Vol.29, p.viii587-viii588

2018

Volltextzugriff (PDF)

A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas

Annals of oncology, 2017-01, Vol.28 (1), p.121-127

2017

Volltextzugriff (PDF)

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

Annals of oncology, 2018-10, Vol.29, p.viii579-viii579

2018

Volltextzugriff (PDF)

Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus report

ESMO open, 2024-07, Vol.9 (7), p.103487, Article 103487

2024

Volltextzugriff (PDF)

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)

Annals of oncology, 2018-10, Vol.29, p.viii581-viii582

2018

Volltextzugriff (PDF)

Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)

Annals of oncology, 2018-10, Vol.29, p.viii670-viii670

2018

Volltextzugriff (PDF)

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950)

Annals of oncology, 2018-10, Vol.29, p.viii580-viii580

2018

Volltextzugriff (PDF)

Advances in Adjuvant Therapy of Gastrointestinal Stromal Tumors

Current oncology reports, 2012-08, Vol.14 (4), p.327-332

2012

Volltextzugriff (PDF)

State-of-the-art management of nasopharyngeal carcinoma: current and future directions

British journal of cancer, 2005-03, Vol.92 (5), p.799-806

2005

Volltextzugriff (PDF)

3403 Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS)

European journal of cancer (1990), 2015-09, Vol.51, p.S689-S689

2015

Volltextzugriff (PDF)

Whole Field Sequential Intensity Modulated Radiation Therapy (s-IMRT) For Local-Regional Advanced Head-and-Neck Squamous Cell Carcinomas

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S433-S433

2013

Volltextzugriff (PDF)

Effect of Recombinant Human Deoxyribonuclease (rhDNase) on Oropharyngeal Secretions in Patients with Head-and-Neck Cancers Treated With Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S63-S63

2012

Volltextzugriff (PDF)

Characterization of Loss of Prognostic Data with Updated Pathologic Nodal Staging System for p16+ Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e323

2022

Volltextzugriff (PDF)

Updated Clinical Nodal Staging System for p16+ Oropharyngeal Squamous Cell Carcinoma Associated with Loss of Prognostic Data

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e323-e324

2022

Volltextzugriff (PDF)

1645PKS in the era of HAART: A single institutional retrospective review

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1929P phase II results from the RINGSIDE phase II/III trial of AL102 for treatment of desmoid tumors

Annals of oncology, 2023-10, Vol.34, p.S1037-S1037

2023

Volltextzugriff (PDF)

1726MO Updated efficacy and safety of botensilimab plus balstilimab in patients with refractory metastatic sarcoma from an expanded phase I study

Annals of oncology, 2024-09, Vol.35, p.S1034-S1034

2024

Volltextzugriff (PDF)

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

OncoTargets and therapy, 2013-01, Vol.6 (default), p.135-143

2013

Volltextzugriff (PDF)

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(244)
Mit Volltextzugriff
(212)

Publikationsform

Sprache

Englisch
(264)
Russisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

Oral complications of targeted cancer therapies: A narrative literature review

KS in the era of HAART: A single institutional retrospective review

Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy

Trends in Head and Neck Squamous Cell Carcinoma (HNSCC) Clinical Research as Reported in the American Society of Clinical Oncology (ASCO) Proceedings From 1996 to 2015

Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

Perceptions of clinical trial enrollment in patients with bone and soft tissue sarcoma

A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus report

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)

Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950)

Advances in Adjuvant Therapy of Gastrointestinal Stromal Tumors

State-of-the-art management of nasopharyngeal carcinoma: current and future directions

3403 Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS)

Whole Field Sequential Intensity Modulated Radiation Therapy (s-IMRT) For Local-Regional Advanced Head-and-Neck Squamous Cell Carcinomas

Effect of Recombinant Human Deoxyribonuclease (rhDNase) on Oropharyngeal Secretions in Patients with Head-and-Neck Cancers Treated With Chemoradiation Therapy

Characterization of Loss of Prognostic Data with Updated Pathologic Nodal Staging System for p16+ Oropharyngeal Squamous Cell Carcinoma

Updated Clinical Nodal Staging System for p16+ Oropharyngeal Squamous Cell Carcinoma Associated with Loss of Prognostic Data

1645PKS in the era of HAART: A single institutional retrospective review

1929P phase II results from the RINGSIDE phase II/III trial of AL102 for treatment of desmoid tumors

1726MO Updated efficacy and safety of botensilimab plus balstilimab in patients with refractory metastatic sarcoma from an expanded phase I study

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

Suchergebnisse filtern